Session Details
[1PS1-04]【J】Recent Advances in Disease Research Using Human Stem Cell Models
Tue. Dec 1, 2026 5:15 PM - 6:45 PM JST
Tue. Dec 1, 2026 8:15 AM - 9:45 AM UTC
Tue. Dec 1, 2026 8:15 AM - 9:45 AM UTC
Room 4 (Conference Center 3F 303)
Organizers: Yohei Hayashi (CiRA Foundation), Yuichiro Miyaoka (Tokyo Metropolitan Institute of Medical Sciences)
Research using human stem cells such as iPS cells, when combined with organoid technology that reproduces organ structures in three-dimensional cultures and precise genome editing techniques, enables a more detailed elucidation of disease pathogenesis mechanisms. This is accelerating applications in drug discovery and personalised medicine. This symposium will introduce the cutting-edge studies based on these human stem cell control technologies and discuss their future perspectives in various disease studies.
[1PS1-04-01]Development of human tetraploid iPSCs platform and its application to polyploid research
○Tomoko Kato-Inui1, Ittetsu Nakajima1,2, Kai Zhang1,2, Miyu Kinoshita1,2, Kayoko Shinozaki1,2, Kanata Imamura1,2, Moe Sato1,2, Yuichiro Miyaoka1,2,3 (1. Regenerative Medicine Project, TMIMS, 2. Grad. Sch. Med. Dent. Sci, Science Tokyo, 3. Grad. Sch. Hum. Sci, Ochanomizu Univ.)
Q & A for Each Presentation
[1PS1-04-02]Identification of a Probabilistic Three-Stage AND-Gate Checkpoint Model Governing Reprogramming Outcome in Human Dermal Fibroblasts
○Masato Nakagawa1,2, Satomi Masai1,3,4, Kotone Aoyama1,5, Ren Takimoto6, Nozomu Yachie2,6,7,8 (1. CiRA, Kyoto University , 2. WPI-PRIMe, The University of Osaka, 3. Division of Medical Science, Graduate School of Medicine, Kyoto University, 4. Research Fellow, JSPS, 5. ivision of Medical Science, Graduate School of Medicine, Kyoto University, 6. School of Biomedical Engineering, The University of British Columbia, 7. CREST Cell Control Program, JST, 8. The McMillan Multiscale Human Program, the Canadian Institute for Advanced Research)
Q & A for Each Presentation
[1PS1-04-03]Generation of Region-Specific Cartilage and Reconstruction of Human Limb Skeletogenesis Using iPS Cells
○Takeshi Takarada1,2 (1. Faculty of Advanced Research Fields,Okayama University, 2. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences (Medicine),Okayama University)
Q & A for Each Presentation
[1PS1-04-04]Development of a Pathological Model of Neural Crest Disorders and New Treatments Using iPS Cells Derived from Patients with Chromosomal Deletions
○Hayashi Yohei1 (1. CiRA Foundation)
Q & A for Each Presentation
[1PS1-04-05]A Cell Therapy Approach for Hirschsprung’s Disease Using induced Pluripotent Stem Cell-derived Enteric Neural Progenitor Cells
○Makoto Ikeya1,2 (1. Kyoto University, 2. T-CiRA)
